Biora Therapeutics Home
Activate the mobile navigation
Close the mobile navigation
Close
Home
Company
About
Quality
Careers
Platforms
BioJet Oral Therapeutic Delivery
NaviCap Targeted Therapeutic Delivery
Publications
News
Press Releases
Investor FAQs
Contact
Toggle the search bar
Search the Site
Close the mobile navigation
Publications
Select Category
Select Category...
BioJet Oral Therapeutic Delivery
NaviCap Targeted Therapeutic Delivery
SIBO & Microbiome
A novel method for collecting microbiome specimens: proof of concept in normal healthy volunteers
May 24, 2022
#SIBO & Microbiome
Evaluation of novel lab-in-a-capsule technology for SIBO diagnosis
November 23, 2020
#SIBO & Microbiome
SIBO diagnosis: clinical survey of practice patterns, unmet needs, and perception of a novel ingestible diagnostic capsule
November 9, 2020
#SIBO & Microbiome
Characterization of the bacterial makeup and quantitative distribution in patients with suspected small intestine bacterial overgrowth (SIBO): A meta-analysis
October 28, 2019
#SIBO & Microbiome
Accuracy of glucose breath testing for small intestine bacterial overgrowth (SIBO) using endoscopy aspirate cultures as a reference standard: A meta-analysis
October 28, 2019
#SIBO & Microbiome
Development of a swallowable diagnostic capsule to monitor gastrointestinal health
May 17, 2019
#SIBO & Microbiome
Development of targeted therapeutic antibodies for the treatment of inflammatory bowel disease: A proof of concept
May 17, 2019
#SIBO & Microbiome
A comparison of systemic versus targeted anti-TNFα antibody in treatment of colitis induced by adoptive transfer of CD44-/CD62L+ T-cells into RAG2-/- mice recipients
May 17, 2019
#SIBO & Microbiome
Connect with us
Email Us
Biora Therapeutics Linkedin
Biora Therapeutics Twitter